Bernd Schnabl

Active 2001–2026

187
Papers
30,806
Citations
87
h-index
181
i10-index

Citations

Citations per year for Bernd Schnabl1966: 3 citations1996: 3 citations1997: 7 citations2002: 11 citations2003: 41 citations2004: 21 citations2005: 40 citations2006: 24 citations2007: 28 citations2008: 46 citations2009: 59 citations2010: 97 citations2011: 100 citations2012: 149 citations2013: 194 citations2014: 224 citations2015: 321 citations2016: 335 citations2017: 386 citations2018: 444 citations2019: 1,283 citations2020: 1,903 citations2021: 2,079 citations2022: 2,001 citations2023: 1,839 citations2024: 2,558 citations2025: 1,600 citations2026: 31 citations1967–1995: no citations, so these years are not shown1998–2001: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorChina: 3,992 citing papers, 24.8% of this breakdownUnited States: 3,448 citing papers, 21.5% of this breakdownGermany: 762 citing papers, 4.7% of this breakdownUnited Kingdom: 715 citing papers, 4.5% of this breakdownItaly: 695 citing papers, 4.3% of this breakdownSpain: 519 citing papers, 3.2% of this breakdownFrance: 468 citing papers, 2.9% of this breakdownJapan: 437 citing papers, 2.7% of this breakdownCanada: 400 citing papers, 2.5% of this breakdownSouth Korea: 345 citing papers, 2.1% of this breakdownIndia: 331 citing papers, 2.1% of this breakdownAustralia: 283 citing papers, 1.8% of this breakdown
0%24.8%Other 22.9%

Fields

  • Medicine50.4%
  • Biochemistry, Genetics and Molecular Biology34.3%
  • Immunology and Microbiology6.5%
  • Environmental Science1.9%
  • Neuroscience1.8%
  • Agricultural and Biological Sciences1.7%
  • Other3.4%

Topics

  • Gut microbiota and health11.5%
  • Liver Disease Diagnosis and Treatment11.2%
  • Diet and metabolism studies3.6%
  • Liver Disease and Transplantation3.5%
  • Alcohol Consumption and Health Effects2.9%
  • Clostridium difficile and Clostridium perfringens research2.4%
  • Other64.9%

Coauthors

All papers

Open in search
  1. New mitochondrial DNA synthesis enables NLRP3 inflammasome activation

    Authors: , , , , , , , , , , , , , - Nature 2018 cited by 1,187

  2. The gut–liver axis and gut microbiota in health and liver disease

    Authors: , - Nature Reviews Microbiology 2023 cited by 615

  3. The gut–liver axis and the intersection with the microbiome

    Authors: , , , , , , - Nature Reviews Gastroenterology & Hepatology 2018 cited by 1,424

  4. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2017 cited by 1,097

  5. Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Debbie L. Shawcross, Samuel B. Ho, Alexandre Louvet, Michael R. Lucey, Philippe Mathurin, Guadalupe García–Tsao, Ramón Bataller, Xin Tu, Lars Eckmann, Wilfred A. van der Donk, Ry Young, Trevor D. Lawley, Peter Stärkel, David T. Pride, Derrick E. Fouts, Bernd Schnabl - Nature 2019 cited by 837

  6. Gut microbiome, liver immunology, and liver diseases

    Authors: , , , , , - Cellular and Molecular Immunology 2020 cited by 448

  7. Adenoma-linked barrier defects and microbial products drive IL-23/IL-17-mediated tumour growth

    Authors: , , , , , , , , , , , , , , , , , , , , - Nature 2012 cited by 1,319

  8. Bacteria engineered to produce IL-22 in intestine induce expression of REG3G to reduce ethanol-induced liver disease in mice

    Authors: , , , , , , , , , , , , , - Gut 2018 cited by 352

  9. FXR Regulates Intestinal Cancer Stem Cell Proliferation

    Authors: , , , , , , , , , , , , , , , , , , , - Cell 2019 cited by 470

  10. Interactions Between the Intestinal Microbiome and Liver Diseases

    Authors: , - Gastroenterology 2014 cited by 973

  11. Gut Microbiome Directs Hepatocytes to Recruit MDSCs and Promote Cholangiocarcinoma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Tim F. Greten - Cancer Discovery 2020 cited by 245

  12. Microbiota and Fatty Liver Disease—the Known, the Unknown, and the Future

    Authors: , - Cell Host & Microbe 2020 cited by 229

  13. Enteric dysbiosis associated with a mouse model of alcoholic liver disease

    Authors: , , , , , , , , , - Hepatology 2010 cited by 780

  14. The fecal mycobiome in non-alcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2021 cited by 185

  15. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2015 cited by 711

  16. Intestinal fungi contribute to development of alcoholic liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2017 cited by 464

  17. Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice

    Authors: , , , , , , , , - Gastroenterology 2010 cited by 731

  18. Intestinal Virome Signature Associated With Severity of Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , , , , , , , , , , - Gastroenterology 2020 cited by 206

  19. The microbiota in cirrhosis and its role in hepatic decompensation

    Authors: , , , , - Journal of Hepatology 2021 cited by 254

  20. Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Hepatology 2019 cited by 236

  21. The Candida albicans exotoxin candidalysin promotes alcohol-associated liver disease

    Authors: , , , , , , , , , , , , , , , , - Journal of Hepatology 2019 cited by 228

  22. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non‐alcoholic fatty liver disease

    Authors: , , , , , , , , , , , , - British Journal of Pharmacology 2017 cited by 199

  23. Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting

    Authors: , , , , , , , , , , , , , , , - Gut 2019 cited by 195

  24. An Introduction to Next Generation Sequencing Bioinformatic Analysis in Gut Microbiome Studies

    Authors: , , , , , , , , , - Biomolecules 2021 cited by 157